Analysts Are Bullish on These Healthcare Stocks: KMDA, AAAP

By Ryan Adsit

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Kamada (NASDAQ: KMDA) and Advanced Accelerator Applications (NASDAQ: AAAP) with bullish sentiments.

Kamada (NASDAQ: KMDA)

Jefferies analyst Raj Denhoy reiterated a Buy rating on Kamada (NASDAQ: KMDA) yesterday and set a price target of $9. The company’s shares opened today at $6.95, close to its 52-week high of $7.34.

According to TipRanks.com, Denhoy is a top 100 analyst with an average return of 15.1% and a 70.4% success rate. Denhoy covers the Healthcare sector, focusing on stocks such as Boston Scientific Corp, Zimmer Biomet Holdings, and Varian Medical Systems.

Kamada has an analyst consensus of Moderate Buy, with a price target consensus of $9.

Advanced Accelerator Applications (NASDAQ: AAAP)

In a report released today, Peter Welford from Jefferies reiterated a Buy rating on Advanced Accelerator Applications (NASDAQ: AAAP), with a price target of $50. The company’s shares opened today at $35.99.

According to TipRanks.com, Welford is a 5-star analyst with an average return of 17.1% and a 75.0% success rate. Welford covers the Healthcare sector, focusing on stocks such as Protalix Biotherapeutics, Karyopharm Therapeutics, and Vertex Pharmaceuticals.

Advanced Accelerator Applications has an analyst consensus of Moderate Buy, with a price target consensus of $48.50.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.